Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine Plus EBMP vs EBMP Alone in Adults With Interstitial Cystitis/Bladder Pain Syndrome
NCT07698626Phase 1Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2026
- Primary completion
- Dec 2027
01
Overview
Phase 1, randomised, single-blind trial of venlafaxine in bladder pain syndrome (BPS) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Global Response Assessment at 12 weeks. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
venlafaxine
03
Conditions
bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT07698626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07698626.